SHANGHAI, Sept. 23, 2019 /PRNewswire/ -- The world's leading online healthcare ecosystem platform, Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor"; stock code: 01833.HK) announced on 23 September that the number of registered users on Ping An Good Doctor exceeded 300 million

The intellectual property enables the creation and formulation of premium infused products, delivers a repeatable consumer experience, and can be produced at mass market scale VANCOUVER, Sept. 23, 2019 /PRNewswire/ - Nextleaf Solutions Ltd. ("Nextleaf", "OILS", or the "Company") (CSE: OILS) (OTCQB: OILFF)&nbs

LEEDS, England, Sept. 23, 2019 /PRNewswire/ -- 4D pharma plc (the "Company" or "4D") (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces the publication of a paper outlining the ability of MRx0005 and MRx0029 to modulate neuroinflammatory and neurodegenerative processes in vitro. The paper 'In vitro

Not intended for UK-based mediaKey ESMO Abstracts # BAVENCIO® (avelumab): 1451; 3152; 4174; 4256; 4823; 5113, ERBITUX® (cetuximab): 1212, 2589, 4455, Tepotinib (MET kinase inhibitor): 3930; 5373; 5455, M6620 (ATR inhibitor): 1547, Combinations: 4062; 4934.New subgroup analyses for first-line treatment of advanced renal cell carcinoma

TAIPEI, Sept. 23, 2019 /PRNewswire/ -- The Innovative Invention Pavilion at the Taiwan Innotech Expo (TIE), co-hosted by the Ministry of Science and Technology and the Ministry of Education and executed by Industrial Technology Research Institute, will be held at Taipei World Trade Center Hall 1 on September 26, 2019

NEW YORK, Sept. 23, 2019 /PRNewswire/ -- The global medical technology (medtech) industry continues to grow, but its long-term growth outlook is at risk due to underinvestment in R&D and lack of collaboration between industry providers, payers and patients. The 2019 EY medtech report, Pulse of the Industry, has found that in 2018-2019 the industry's colle

SUZHOU, China, Sept. 21, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced results from the microsatellite instability high/deficient mismatch repair (MSI-H/dMMR) solid tumor cohort in the GEMSTONE-101 Phase Ib study of the Company's investigational anti-PD-L1 antibody CS1001 for the first time in an oral presentation at

SUZHOU, China, Sept. 21, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced preliminary results from the Phase Ia trial of the Company's anti-CTLA-4 antibody in an oral presentation at the 22nd Annual Meeting of the Chinese Society of Clinical Oncology (CSCO, 2019 CSCO Annual Meeting). This presentation marks the firs

WASHINGTON, Sept. 21, 2019 /PRNewswire/ -- Just in time for World Alzheimer's Day, a group of young activists in their 20's have created a nationwide call to action for presidential candidates to take action on Alzheimer's disease. Spearheaded by

PARIS, Sept. 21, 2019 /PRNewswire/ -- Chronic kidney disease affects 1 out of 10 people worldwide and is steadily increasing. When it reaches end-stage renal disease and endangers the lives of patients, dialysis or transplantation is required. Renal transplantation is the treatment of choice, offering a better quality of life and survival chances to patients. Unfortunate